Advancing the Use of AI Tools in Hepatology Drug Development

Understand the challenges faced by biotech sponsors in hepatology drug development and clinical trials. Tap into expert insights to learn how AI is poised to provide solutions for moving forward.

Download your copy of the roundtable summary of a recent panel discussion held at EASL Congress 2025 and sponsored by Novotech.

Read the summary to learn:

What the main areas of difficulty are for hepatology drug developers
How AI may help with the ongoing challenges of patient engagement, data, and operational tasks
How AI may enable personalized medicine for hepatology patients
What ethical and regulatory issues the industry must consider when using AI

Download the Roundtable summary

Your Company Email Address

Opt In?

By completing this form You agree Citeline and Novotech Pty Limited. may contact you directly about industry news, products, services and events that may be of interest to you subject to the privacy policies of Citeline and Novotech Pty Limited.